Diagnostic value of plasma cell-free DNA metagenomic next-generation sequencing in patients with suspected infections and exploration of clinical scenarios—a retrospective study from a single center
Authors:
Open Access
- 2 January 2026
- journal article
- infectious diseases
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2608531
Abstract
Plasma cell-free DNA metagenomic next-generation sequencing (mNGS) is a non-invasive comprehensive method for the etiological diagnosis of various infectious diseases. However, research on the early diagnosis and real-world clinical impact of plasma mNGS in patients with suspected infection are still limited. This study retrospectively included 140 patients with suspected infections who underwent early plasma mNGS and conventional culture testing. Referring to the clinical diagnosis of infectious diseases, the diagnostic performance of plasma mNGS and culture tests was compared, and the application scenarios and clinical effects of plasma mNGS were evaluated. The positive rate of plasma mNGS was significantly higher than that of culture methods (55.71% vs 25.10%, p < 0.001) and blood cultures (55.71% vs 12.86%, p < 0.001). Regarding clinical diagnosis, the sensitivity of plasma mNGS was significantly higher than that of culture (58.27% vs 37.80%, p = 0.002). The combination of mNGS and culture achieved a higher detection sensitivity (69.29%), especially in patients with multi-site co-infections (73.68%) and blood infections (73.17%). Plasma mNGS demonstrated higher sensitivity in patients with procalcitonin (PCT) index > 5 ng/ml or human neutrophil lipocalin (HNL) index > 200 ng/ml. In terms of treatment, a total of 69 patients (54.33%) benefited from plasma mNGS. This study highlights the significant improvement in pathogen detection performance by combining conventional culture with plasma mNGS detection, especially in patients with multi-site co-infections and blood infections. Early use of plasma mNGS as an adjunct to culture can better guide clinicians to initiate appropriate anti-infective therapy.Keywords
Funding Information
- Shandong Provincial Medical and Health Science and Technology Project (202311000239)
This publication has 44 references indexed in Scilit:
- Diagnostic value of plasma and blood cells metagenomic next-generation sequencing in patients with sepsisBiochemical and Biophysical Research Communications, 2023
- Clinical evaluation of cell-free and cellular metagenomic next-generation sequencing of infected body fluidsJournal of Advanced Research, 2023
- Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disordersJournal of Infection, 2022
- Multicenter assessment of shotgun metagenomics for pathogen detectionEBioMedicine, 2021
- Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infectionsJournal of Advanced Research, 2021
- Exploring the Clinical Utility of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary InfectionInfectious Diseases and Therapy, 2021
- High‐Throughput Metagenomics for Identification of Pathogens in the Clinical SettingsSmall Methods, 2020
- Retrospective Validation of a Metagenomic Sequencing Protocol for Combined Detection of RNA and DNA Viruses Using Respiratory Samples from Pediatric PatientsThe Journal of Molecular Diagnostics, 2020
- Procalcitonin levels in bloodstream infections caused by different sources and species of bacteriaThe American Journal of Emergency Medicine, 2017
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012